Advances in Therapy

, Volume 28, Issue 3, pp 195–201 | Cite as

Trends in chronologic age and infant respiratory syncytial virus hospitalization: an 8-year cohort study

  • Jon P. Fryzek
  • William J. Martone
  • Jessie R. Groothuis
Open Access
Original Research

Abstract

Introduction

Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections in infants and young children and the leading cause of hospitalization in infants aged <1 year.

Methods

We examined trends in RSV hospitalization (RSVH) among infants from 1998 to 2006, using the United States (US) National Hospital Discharge Survey (NHDS) database. RSVH was defined by the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes 079.6 (RSV), 466.11 (acute bronchiolitis due to RSV), and 480.1 (pneumonia due to RSV). Age at the time of hospitalization was determined using NHDS birth records; RSVH rates were analyzed for infants grouped into three age cohorts (<3 months, 3 to 6 months, and >6 to <24 months). Trends in hospitalization rates were evaluated using linear regression. Relative rates (RR) and 95% confidence intervals (CI) were computed to compare average RSVH rates for infants across age-specific groups. The annual proportion of RSVH by age group was also calculated.

Results

Approximately 1.1 million (90,000–147,000 per year) RSVHs in predominantly term children aged <24 months were analyzed. Compared with children aged >6 to <24 months, rates for RSVH were significantly higher among infants aged <3 months (RR, 7.38; 95% CI, 7.35–7.41) and infants aged 3 to 6 months (RR, 5.28; 95% CI, 5.26–5.29). The proportion of RSVH in the first year of life was lowest among infants aged <1 month (0.9%). The greatest proportion of RSVH was observed in children aged 3 to 6 months (14%–23% RSVH per year; chi-square P<0.0001). When the definition of RSVH was expanded to include unspecified hospitalizations for acute bronchiolitis, similar results were observed.

Conclusion

RRs were highest among the <3− month and 3- to 6-month age groups. The highest proportion of RSVH was among the 3- to 6-month age group. Analysis of the impact of RSV season, clinical practices, and other factors on these trends is warranted.

Keywords

age hospitalization respiratory syncytial virus young infants 

References

  1. 1.
    Hall CB. Respiratory syncytial virus. In: Feigen RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. Philadelphia, PA: WB Saunders; 1987:1653–1675.Google Scholar
  2. 2.
    Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med. 2001;344:1917–1928.PubMedCrossRefGoogle Scholar
  3. 3.
    Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA. 1999;282:1440–1446.PubMedCrossRefGoogle Scholar
  4. 4.
    Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360:588–598.PubMedCrossRefGoogle Scholar
  5. 5.
    Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr. 2003;143:S127–S132.PubMedGoogle Scholar
  6. 6.
    Dennison C, Pokras R. Design and operation of the National Hospital Discharge Survey: 1988 redesign. Vital Health Stat 1. 2000;39:1–42.PubMedGoogle Scholar
  7. 7.
    American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics. 2003;112:1442–1446.CrossRefGoogle Scholar
  8. 8.
    Holberg CJ, Wright AL, Martinez FD, et al. Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am J Epidemiol. 1991;133:1135–1151.PubMedGoogle Scholar
  9. 9.
    Yeung CY, Hobbs JR. Serum-gamma-G-globulin levels in normal premature, post-mature, and “small-for-dates” newborn babies. Lancet. 1968;1:1167–1170.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Healthcare 2011

Authors and Affiliations

  • Jon P. Fryzek
    • 1
  • William J. Martone
    • 1
  • Jessie R. Groothuis
    • 1
  1. 1.One MedImmune WayGaithersburgUSA

Personalised recommendations